DOUG RICE 4

What Happened Doug Rice, Chief Financial Officer of MiMedx Group, Inc. (MDXG), received equity awards on March 4, 2026: 74,163 shares granted as restricted stock and 62,068 shares recorded as a derivative award. Both transactions show an acquisition price of $0 (awarded as compensation), for a total of 136,231 shares granted. These were reported on a Form 4 filed March 6, 2026.

Key Details

• Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (filed two days after the transactions).
• Awarded shares: 74,163 restricted stock (priced $0) + 62,068 derivative award (priced $0) = 136,231 total awarded.
• Vesting/terms noted in filing:
  • Restricted stock (74,163) vests fully on the third anniversary of the grant, subject to continued employment (F1).
  • The 62,068 derivative award appears subject to vesting per option/award agreement (file includes a standard 25% annual vesting schedule for options) (F3).
• Filing notes it "includes 3,491 shares acquired on January 30, 2026 pursuant to the Employee Stock Purchase Plan" (F2) — the filing does not state a post-transaction total holdings explicitly.
• No sale or exercise reported; these are compensation awards, not open-market purchases or sales.

Context This filing documents compensation grants to the CFO rather than purchases or sales by management. Restricted stock and derivative awards typically vest over time and do not indicate an immediate change in market exposure (no immediate sale or cashless exercise reported). For investors, awarded equity is routine corporate compensation; the vesting schedules determine when the awards may convert into reportable, tradable shares.